Top Story

Patients with type 1 diabetes at increased risk for all-cause, CVD mortality

November 20, 2014

Read the Perspective from Luigi Meneghini, MD, MBA

The likelihood of dying from any cause or cardiovascular causes is two times higher in patients with type 1 diabetes and an HbA1c level ≤6.9% compared with individuals in the general population, according to research published in The New England Journal of Medicine.

Results from an observational study of patients with type 1 diabetes registered in the Swedish National Diabetes Register after Jan. 1, 1998, demonstrated even more dramatic rates for patients with type 1 diabetes who are unable to control their glucose levels.

Varun Kumar, MD Meeting News Coverage

Cocaine use associated with coronary microvascular dysfunction

November 19, 2014
CHICAGO — New data suggest that cocaine users with chest pain may have coronary microvascular dysfunction, despite the absence of significant epicardial…
Anand K. Rohatgi, MD Meeting News Coverage

Cholesterol efflux capacity inversely associated with CV events

November 19, 2014
CHICAGO — Cholesterol efflux capacity, a biomarker of reverse cholesterol transport, was inversely associated with CV events in participants of the Dallas Heart…
Parag Joshi Meeting News CoverageBlog

Late-breaking clinical trials in CVD prevention: Where are the events?

November 18, 2014
by Parag H. Joshi, MD, MHS CHICAGO — The cold weather in Chicago seems to have led to increased attendance at talks, if for nothing else than to stay warm. An…
CME
Practical Lipidology

Practical Lipidology: 2013

This activity is supported by an educational grant from Genentech.

The rise in the prevalence of obesity in the last few decades and its growing impact on health has driven the…
More »
Meeting News Coverage Video
thumbnail for video 3884510502001

Improved survival of liver transplant patients demands treatment strategies for long-range cancer, CVD comorbidities

November 10, 2014
BOSTON — Kymberly D. Watt, MD, hepatologist and medical director of liver transplantation at Mayo Clinic, shares…
More »
CME
Risk Management in the Cardiovascular Disease Arena

Risk Management in the Cardiovascular Disease Arena: Focus on Glycemic Control

This activity is supported by an educational grant from Genentech.

Among the multiple comorbidities and complications that are associated with type 2 diabetes mellitus (T2DM)…
More »
Marcus Lind In the JournalsPerspective

Patients with type 1 diabetes at increased risk for all-cause, CVD mortality

November 20, 2014
The likelihood of dying from any cause or cardiovascular causes is two times higher in patients with type 1 diabetes and an HbA1c level ≤6.9%…
Varun Kumar, MD Meeting News Coverage

Cocaine use associated with coronary microvascular dysfunction

November 19, 2014
CHICAGO — New data suggest that cocaine users with chest pain may have coronary microvascular dysfunction, despite the absence of significant…
Anand K. Rohatgi, MD Meeting News Coverage

Cholesterol efflux capacity inversely associated with CV events

November 19, 2014
CHICAGO — Cholesterol efflux capacity, a biomarker of reverse cholesterol transport, was inversely associated with CV events in participants of…
Parag Joshi Meeting News CoverageBlog

Late-breaking clinical trials in CVD prevention: Where are the events?

November 18, 2014
by Parag H. Joshi, MD, MHS CHICAGO — The cold weather in Chicago seems to have led to increased attendance at talks, if for nothing else than…
Meeting News CoveragePerspective

INHERIT: Losartan did not improve left ventricular mass in patients with hypertrophic cardiomyopathy

November 18, 2014
CHICAGO — Use of losartan in patients with overt hypertrophic cardiomyopathy had no effect on left ventricular mass or endpoints such as…
Mikhail N. Kosiborod, MD Meeting News Coverage

HARMONIZE: ZS-9 reduced serum potassium in patients with hyperkalemia

November 18, 2014
CHICAGO — Treatment with sodium zirconium cyclosilicate was associated with rapid and sustained reductions in serum potassium compared with…
Meeting News Coverage

Aspirin failed to reduce events in older Japanese patients

November 18, 2014
CHICAGO — Daily, low-dose aspirin did not decrease long-term atherosclerotic events compared with no aspirin use in a study of elderly Japanese…
Mohammed Ali In the Journals

'Cascade-of-care' displays gaps in US diabetes diagnosis, treatment

November 17, 2014
Using a cascade model to visualize the gaps in awareness of diabetes diagnosis, engagement in care and treatment in the United States, researchers…
Healio AHA2014 Underberg th Meeting News CoverageVideo

IMPROVE-IT results provide long-awaited answers

November 17, 2014
CHICAGO – In this video, James A. Underberg, MD, discusses the highly anticipated results of IMPROVE-IT, a trial that examined the effects of…
John Morton Meeting News CoveragePerspective

Medication reduction, cost savings seen after bariatric surgery

November 17, 2014
Patients with obesity who underwent bariatric surgery significantly reduced their medication use and saved on drug costs compared with those who did…
More Headlines »
morganatic-roan
morganatic-roan